The trajectory of therapeutic innovation in the Schnitzler Syndrome Disease Treatment Market is poised for significant shifts, necessitating meticulous market forecasting to anticipate the impact of emerging pipeline assets and changes in clinical practice. While IL-1 antagonism is highly effective, the field is exploring next-generation approaches, including small molecule inhibitors...